Form 4: Phreesia Director Michael Weintraub Executes Stock Transactions Under 10b5-1 Plan

Director Michael Weintraub of Phreesia, Inc. executed a series of stock transactions, including the exercise of stock options and the sale of shares, under a pre-arranged 10b5-1 trading plan.

Summary

• Michael Weintraub, a director at Phreesia, Inc., engaged in stock transactions on December 11, 2024.
• These transactions included the acquisition of 18,574 shares of common stock through the exercise of stock options at a price of $4.71 per share.
• Concurrently, Mr. Weintraub sold 18,574 shares of common stock at a weighted average price of $25.0991 per share, with individual sales ranging from $25.00 to $25.31.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 6, 2024.
• Following these transactions, Mr. Weintraub directly owns 242,827 shares of common stock.
• He also has indirect ownership of 91,045 shares through the Michael Weintraub 2023 Qualified Annuity Trust and 6,703 shares through the Weintraub Family 2017 Irrevocable Trust.

Sentiment

Score: 5

Explanation: The document reflects routine insider transactions under a pre-arranged plan, which is neither particularly positive nor negative. The sale of shares is balanced by the exercise of options.

Positives

• The exercise of stock options indicates a potential positive outlook on the company's future by the director.
• The pre-planned nature of the transactions under Rule 10b5-1 suggests an orderly and transparent approach to stock trading.

Negatives

• The sale of shares, even under a pre-planned strategy, could be interpreted as a lack of confidence in the company's short-term prospects by some investors.

Risks

• The market may react negatively to the sale of shares by a director, even if it is part of a pre-planned strategy.
• The price fluctuations during the sale period could introduce volatility in the stock price.

Industry Context

This type of transaction is common for corporate insiders who use 10b5-1 plans to manage their stock holdings and avoid accusations of insider trading. It is a routine disclosure and does not necessarily indicate a change in the company's fundamentals.

Comparison to Industry Standards

• Transactions under Rule 10b5-1 are a standard practice among publicly traded companies, including those in the healthcare technology sector like Phreesia.
• Similar transactions are often seen in companies like Veeva Systems and athenahealth, where executives and directors use these plans for regular stock sales and option exercises.
• The reported price range and volume of shares traded are within the typical range for such transactions.

Stakeholder Impact

• The transactions may have a minor impact on the stock price, but the pre-planned nature should mitigate any significant negative reaction.
• Shareholders may view the transactions as a routine part of insider compensation and portfolio management.

Key Dates

Keywords

Phreesia, Michael Weintraub, stock options, stock sale, Rule 10b5-1, insider trading, beneficial ownership, director